Who are Ethypharm's investors?

Ethypharm's investors include Astorg.

Ethypharm

Founded 1977 · 1,139 employees on LinkedIn · 1 known investors

Find your way into Ethypharm

Each arrow is one introduction. Sign up to fill in the first one.

287 people can intro you to Denis

Ask Pierre Moustial to introduce you to Denis Delval

You →Pierre · together at Fournier Pharma →Denis

140 people can intro you to Foucauld

Ask Jamie Chen to introduce you to Foucauld Ruyant

You →Jamie · together at SUNTORY BEVERAGE & FOOD EUROPE →Foucauld

107 people can intro you to Xavier

Ask Sam Okafor to introduce you to Xavier Lasserre

You →Sam · together at Sandoz →Xavier

Guilhem Maraval62 people can intro you
Cecile Paillous21 people can intro you

Your email: who you already know at Ethypharm, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ethypharm team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Ethypharm is a specialty pharmaceutical company that develops and provides injectable medicines focused on Central Nervous System conditions including severe pain and addiction treatment, as well as critical care hospital injectables. The company serves patients and healthcare providers in hospital and emergency care settings.

Biotech Healthtech Medical Devices

Founders & leadership

Denis Delval President & CEODenis Delval is President and CEO of Ethypharm, a specialty pharmaceutical company developing injectable medicines for central nervous system conditions and critical care. He previously served as CEO of LFB, an international biopharma company focused on plasma derivatives, where he oversaw business restructuring, international expansion, and manufacturing improvements.

Eric ChevalierChief People Officer

Roseline JoannesseChief Legal, Ethics & Compliance Officer

Foucauld Ruyant Chief Financial OfficerHe previously held financial leadership roles in large regulated organizations, including managing a €900M business unit and directing financial planning and analysis for a €1.8B group, with expertise in financial transformation, consolidation, and working capital optimization.

Cecile Paillous Chief Scientific Affairs OfficerCecile Paillous holds an Industrial Pharmacist degree and an MBA-equivalent in Quality Management from ESC Paris. She has spent over 20 years at Ethypharm leading pharmaceutical quality systems, GMP compliance, and quality assurance operations, with prior experience as an ISO consultant in medical devices and pharmaceuticals.

Xavier Lasserre Chief Commercial Operations OfficerXavier Lasserre is Chief Commercial Operations Officer at Ethypharm, a specialty pharmaceutical company developing injectable medicines for CNS conditions and critical care. He brings 25 years of healthcare industry experience across generics, OTC, and hospital business in European and emerging markets, with previous executive roles in operations, business transformation, and private equity-backed healthcare companies.

Guilhem Maraval Chief Operating OfficerGuilhem Maraval is Chief Operating Officer of Ethypharm, a European specialty pharmaceutical company that develops injectable medicines for central nervous system conditions, pain management, addiction treatment, and critical care applications distributed across more than 80 countries.

Investors · 1

Astorglisted by AstorgParis

How we know: Astorg's portfolio page · Not right? Tell us

Frequently asked questions

What does Ethypharm do?: Ethypharm is a specialty pharmaceutical company that develops and provides injectable medicines focused on Central Nervous System conditions including severe pain and addiction treatment, as well as critical care hospital injectables. The company serves patients and healthcare providers in hospital and emergency care settings.
Who are Ethypharm's investors?: Ethypharm's investors include Astorg.